The Institute for Clinical Systems Improvement (ICSI) guideline 1 recommends treatment with double-strength trimethoprim/sulfa-methoxazole (Bactrim DS, Septra
V
Use of ciprofloxacin can be considered in patients with known-susceptible isolates or with non-lactose fermenting organisms in the urine